January 2026 Stock Losers on News
Ranked by the close-to-close change of the trading session each announcement landed in. How this is measured.
Data as of the trading session of , 20 of 20 completed market sessions produced ranked moves. Follow-through dates run later.
Whole board, unfiltered
98
Ranked drops
-91.51%
Largest, QNCX
98.0%
Below baseline, day +5
13.7%
Median deeper below baseline, day +5
Filter and sort
98 ranked drops in January 2026
Skip the ranked rows and go to the month summaryEvery percentage on a row, the follow-through readings included, is measured against that row's own pre-news close, which the row names. A day +5 reading is therefore the move from before the announcement, not a further change on top of the headline percentage.
| Rank | Symbol | close to close | Session | Catalyst | Announcement | from the pre-news close |
|---|---|---|---|---|---|---|
| 1 | QNCX Quince Therapeutics, Inc. | -91.51% |
against the close of 2026-01-28
Session detail |
Clinical Trial Results |
Quince Therapeutics Announces Topline Results from Pivotal Phase 3 NEAT Clinical Trial of eDSP in Ataxia-Telangiectasia
15:10 ET intraday |
Five sessions later the drop was 4.3% bigger, at -95.41%. Month end -94.65% on 2026-01-30 This month ended before the fifth session after the move. |
| 2 | GUTS Fractyl Health, Inc. | -68.04% |
against the close of 2026-01-28
Session detail |
Other Announcement |
Fractyl Health Announces Compelling 6-Month Randomized REMAIN-1 Midpoint Data Showing Durable Weight Maintenance with Revita® After GLP-1 Discontinuation
07:00 ET premarket |
Five sessions later the drop was 14.8% bigger, at -78.14%. Month end -74.86% on 2026-01-30 This month ended before the fifth session after the move. |
| 3 | OTLK Outlook Therapeutics, Inc. | -58.23% |
against the close of 2025-12-31
Session detail |
FDA & Regulatory |
Outlook Therapeutics Provides Regulatory Update on U.S. Food and Drug Administration Review of ONS-5010/LYTENAVA™ (bevacizumab-vikg) for the Treatment of Wet AMD
16:15 ET after hours |
Five sessions later the drop was 7.6% bigger, at -62.66%. Month end -72.17% on 2026-01-30 |
| 4 | ATRA Atara Biotherapeutics, Inc release reads positive | -56.99% |
against the close of 2026-01-09
Session detail |
Clinical Trial Results catalyst from a later release the same session Release reads positive, stock fell 56.99% |
Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLO™ (tabelecleucel)
08:00 ET premarket |
Five sessions later the drop was 20.0% bigger, at -68.40%. Month end -61.96% on 2026-01-30 |
| 5 | BNAI Brand Engagement Network Inc. Also on the opposite board this month on both boards | -52.97% |
against the close of 2026-01-29
Session detail |
Offering / Dilution |
Brand Engagement Network Secures $1.518M Premium Private Placement at $63.25 a Share, Strengthens Balance Sheet with $818K in Warrant Proceeds, Full Debt Repayment
06:10 ET premarket |
Five sessions later the drop was 8.2% bigger, at -57.34%. Month end -52.97% on 2026-01-30 same session This month ended before the fifth session after the move. |
| 6 | ZBIO Zenas BioPharma, Inc. | -51.86% |
against the close of 2026-01-02
Session detail |
Clinical Trial Results |
Zenas BioPharma Announces Positive Results from Phase 3 INDIGO Registrational Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD)
07:05 ET premarket |
17.7% of the drop was recovered five sessions later. Month end -46.75% on 2026-01-30 |
| 7 | TIL Instil Bio, Inc. | -45.81% |
against the close of 2026-01-05
Session detail |
Clinical Trial Results (terminated) |
Instil Bio’s Subsidiary Discontinues Clinical Development of AXN-2510 and Terminates License and Collaboration Agreement with ImmuneOnco
07:00 ET premarket |
9.6% of the drop was recovered five sessions later. Month end -42.55% on 2026-01-30 |
| 8 | IMRX Immuneering Corporation | -43.22% |
against the close of 2026-01-07
Session detail |
Clinical Trial Results |
Immuneering Announces Exceptional 64% Overall Survival At 12 Months in First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP
16:00 ET after hours |
Five sessions later the drop was 2.5% bigger, at -44.30%. Month end -44.42% on 2026-01-30 |
| 9 | VENU Venu Holding Corporation | -40.16% |
against the close of 2026-01-27
Session detail |
Offering / Dilution |
Venu Holding Corporation Announces Proposed Public Offering of Common Stock
16:03 ET after hours |
20.0% of the drop was recovered five sessions later. Month end -36.09% on 2026-01-30 This month ended before the fifth session after the move. |
| 10 | MOBX Mobix Labs, Inc. Also on the opposite board this month on both boards | -40.11% |
against the close of 2026-01-05
Session detail |
Offering / Dilution |
Mobix Labs, Inc. Announces Proposed Public Offering of Common Stock
16:19 ET after hours |
33.1% of the drop was recovered five sessions later. Month end -39.41% on 2026-01-30 |
| 11 | AVX Avax One Technology Ltd. | -39.88% |
against the close of 2026-01-26
Session detail |
Crypto & Treasury |
AVAX One Highlights Institutional Onchain Finance Strategy in New Investor Presentation
09:00 ET premarket |
Five sessions later the drop was 47.5% bigger, at -58.82%. Month end -53.13% on 2026-01-30 This month ended before the fifth session after the move. |
| 12 | PSTV PLUS THERAPEUTICS, Inc. | -38.23% |
against the close of 2026-01-13
Session detail |
Offering / Dilution |
Plus Therapeutics Announces Pricing of Upsized $15 Million Public Offering
08:00 ET premarket |
Five sessions later the drop was 3.0% bigger, at -39.37%. Month end -51.48% on 2026-01-30 |
| 13 | SEV Aptera Motors Corp. | -37.76% |
against the close of 2026-01-22
Session detail |
Offering / Dilution |
Aptera Motors Announces Pricing of $9 Million Public Offering
08:00 ET premarket |
Five sessions later the drop was 1.1% bigger, at -38.17%. Month end -38.17% on 2026-01-30 |
| 14 | SAFX | -37.15% |
against the close of 2026-01-27
Session detail |
Other Announcement |
DevvStream, Southern, and Frontline BioEnergy to Advance Biomass-to-Jet Development and Environmental-Asset Monetization
08:30 ET premarket |
Five sessions later the drop was 11.5% bigger, at -41.43%. Month end -26.36% on 2026-01-30 This month ended before the fifth session after the move. |
| 15 | BBNX Beta Bionics, Inc. | -37.04% |
against the close of 2026-01-08
Session detail |
Earnings |
Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics
16:04 ET after hours |
Five sessions later the drop was 13.8% bigger, at -42.17%. Month end -56.77% on 2026-01-30 |
| 16 | AQST Aquestive Therapeutics, Inc. | -37.04% |
against the close of 2026-01-08
Session detail |
Other Announcement |
Aquestive Therapeutics Announces Regulatory Development for Anaphylm™ (dibutepinephrine) Sublingual Film and Provides Business Update
07:00 ET premarket |
Five sessions later the drop was 26.1% bigger, at -46.70%. Month end -52.50% on 2026-01-30 |
| 17 | ACRV Acrivon Therapeutics, Inc. Also on the opposite board this month on both boards | -34.58% |
against the close of 2026-01-07
Session detail |
Clinical Trial Results |
Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11
07:30 ET premarket |
Five sessions later the drop was 5.9% bigger, at -36.61%. Month end -39.32% on 2026-01-30 |
| 18 | PFSI PennyMac Financial Services, Inc. | -33.25% |
against the close of 2026-01-29
Session detail |
Earnings |
PennyMac Mortgage Investment Trust Reports Fourth Quarter and Full-Year 2025 Results
16:16 ET after hours |
Five sessions later the drop was 8.7% bigger, at -36.14%. Month end -33.25% on 2026-01-30 same session This month ended before the fifth session after the move. |
| 19 | CRMD CorMedix Inc. | -32.77% |
against the close of 2026-01-07
Session detail |
Earnings |
CorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates
08:00 ET premarket |
Five sessions later the drop was 13.6% bigger, at -37.24%. Month end -30.53% on 2026-01-30 |
| 20 | CRDF Cardiff Oncology, Inc. | -31.97% |
against the close of 2026-01-26
Session detail |
Clinical Trial Results |
Cardiff Oncology Announces Positive Update from its Randomized Phase 2 Trial of Onvansertib in First-line RAS-mutated mCRC
07:05 ET premarket |
Five sessions later the drop was 34.1% bigger, at -42.86%. Month end -40.48% on 2026-01-30 This month ended before the fifth session after the move. |
| 21 | CVLT | -31.10% |
against the close of 2026-01-26
Session detail |
Earnings |
Commvault Announces Third Quarter Fiscal 2026 Financial Results
07:45 ET premarket |
Five sessions later the drop was 18.3% bigger, at -36.80%. Month end -33.75% on 2026-01-30 This month ended before the fifth session after the move. |
| 22 | GOAI | -29.53% |
against the close of 2026-01-28
Session detail |
Other Announcement |
Nasdaq Debut Draws Strong Attention with Proprietary A.I. Technology in a 500 Billion Digital Media Advertising.
05:56 ET premarket |
Five sessions later the drop was 100.9% bigger, at -59.32%. Month end -48.56% on 2026-01-30 This month ended before the fifth session after the move. |
| 23 | ROLR High Roller Technologies, Inc. More than one ranked move this month Also on the opposite board this month release reads positive 2+ ranked moves on both boards | -28.93% |
against the close of 2026-01-15
Session detail |
Contract / Partnership Release reads positive, stock fell 28.93% |
High Roller Technologies Signs Letter of Intent with Leverage Game Media to Support U.S. Prediction Markets Launch
09:00 ET premarket |
Five sessions later the drop was 139.9% bigger, at -69.39%. Month end -71.54% on 2026-01-30 |
| 24 | ROLR High Roller Technologies, Inc. More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards | -27.49% |
against the close of 2026-01-16
Session detail |
Offering / Dilution |
High Roller Technologies, Inc. Prices $25 Million Registered Direct Offering
23:12 ET after hours |
Five sessions later the drop was 110.3% bigger, at -57.82%. Month end -59.95% on 2026-01-30 |
| 25 | DCX Digital Currency X Technology Inc. More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards | -25.68% |
against the close of 2026-01-23
Session detail |
Uplisting / Compliance |
Digital Currency X Technology Inc. Announces Receipt of Nasdaq Delisting Notification Letter
16:00 ET after hours |
Five sessions later the drop was 39.4% bigger, at -35.79%. Month end -27.79% on 2026-01-30 This month ended before the fifth session after the move. |
| 26 | MKDW MKDWELL Tech Inc. | -25.43% |
against the close of 2026-01-21
Session detail |
Other Announcement |
MKDWELL Tech Inc. Announces Share Combination on a Thirty-to-one Basis as Part of Strategic Nasdaq Compliance Initiative
11:00 ET intraday |
Five sessions later the drop was 51.6% bigger, at -38.56%. Month end -33.20% on 2026-01-30 |
| 27 | NOMA NOMADAR Corp. release reads positive | -25.24% |
against the close of 2026-01-28
Session detail |
Contract / Partnership Release reads positive, stock fell 25.24% |
Nomadar to Expand Global Presence with Introduction of Digital Soccer Platform in India in Partnership with Actingwood
16:30 ET after hours |
Five sessions later the drop was 16.3% bigger, at -29.35%. Month end -31.31% on 2026-01-30 This month ended before the fifth session after the move. |
| 28 | ELME Elme Communities | -24.66% |
against the close of 2026-01-23
Session detail |
Other Announcement |
Elme Communities Provides Update On Liquidation Activities
16:15 ET after hours |
Five sessions later the drop was 5.5% bigger, at -26.01%. Month end -25.68% on 2026-01-30 This month ended before the fifth session after the move. |
| 29 | BKKT Bakkt, Inc. | -24.52% |
against the close of 2026-01-16
Session detail |
Offering / Dilution |
Bakkt Provides Update on Existing Shelf Registration Statement
09:31 ET intraday |
Five sessions later the drop was 23.2% bigger, at -30.22%. Month end -37.46% on 2026-01-30 |
| 30 | YOUL Youlife Group Inc. American | -23.68% |
against the close of 2026-01-22
Session detail |
Contract / Partnership |
Youlife Group Inc. Announces Non-Binding Letter of Intent with Anlian HR to Advance its OMO Strategy and Strengthen End-to-End Blue-Collar Talent Services
08:00 ET premarket |
Five sessions later the drop was 11.1% bigger, at -26.32%. Month end -26.32% on 2026-01-30 |
| 31 | GNLX Genelux Corporation More than one ranked move this month 2+ ranked moves | -23.52% |
against the close of 2026-01-02
Session detail |
Clinical Trial Results |
Genelux Corporation Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer Trials
08:00 ET premarket |
Five sessions later the drop was 77.6% bigger, at -41.76%. Month end -41.54% on 2026-01-30 |
| 32 | RZLV Rezolve AI PLC | -22.99% |
against the close of 2026-01-16
Session detail |
Offering / Dilution |
Rezolve Ai Announces $250 Million Registered Direct Offering led by Existing and New Fundamental Institutional Investors
11:02 ET intraday |
Five sessions later the drop was 48.2% bigger, at -34.06%. Month end -44.03% on 2026-01-30 |
| 33 | LXEO Lexeo Therapeutics, Inc. | -22.96% |
against the close of 2026-01-09
Session detail |
Clinical Trial Results |
Lexeo Therapeutics Announces Positive Interim Phase I/II Data for LX2020 for the Treatment of PKP2-Associated Arrhythmogenic Cardiomyopathy
07:00 ET premarket |
Five sessions later the drop was 35.5% bigger, at -31.12%. Month end -29.70% on 2026-01-30 |
| 34 | ATEC Alphatec Holdings, Inc. | -22.34% |
against the close of 2026-01-09
Session detail |
Earnings |
ATEC Announces Select Preliminary Financial Results for 2025 and Provides 2026 Outlook
09:05 ET premarket |
Five sessions later the drop was 8.7% bigger, at -24.28%. Month end -34.53% on 2026-01-30 |
| 35 | BENF Beneficient | -22.25% |
against the close of 2026-01-02
Session detail |
Uplisting / Compliance |
Beneficient Regains Full Compliance with Nasdaq Listing Requirements
07:00 ET premarket |
Five sessions later the drop was 19.8% bigger, at -26.65%. Month end -36.95% on 2026-01-30 |
| 36 | SANM Sanmina Corp | -21.56% |
against the close of 2026-01-26
Session detail |
Earnings |
Sanmina Reports First Quarter Fiscal 2026 Financial Results
16:01 ET after hours |
29.1% of the drop was recovered five sessions later. Month end -22.38% on 2026-01-30 This month ended before the fifth session after the move. |
| 37 | GORO | -21.48% |
against the close of 2026-01-20
Session detail |
Earnings |
Gold Resource Corporation Announces Strong Preliminary Year-End Results, Highlighting Operational Turnaround
17:46 ET after hours |
It recovered the whole drop and closed 5.37% above the pre-news price. Month end -10.07% on 2026-01-30 |
| 38 | AGEN Agenus Inc. | -21.37% |
against the close of 2026-01-14
Session detail |
M&A / Acquisition |
Zydus Lifesciences Limited completes the acquisition of Agenus Inc.'s biologics manufacturing facilities, launches Zylidac Bio LLC in the U.S.
08:30 ET premarket |
Five sessions later the drop was 44.0% bigger, at -30.77%. Month end -39.32% on 2026-01-30 |
| 39 | CAMP CAMP4 Therapeutics Corporation | -21.00% |
against the close of 2026-01-16
Session detail |
Other Announcement |
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
16:05 ET after hours |
Five sessions later the drop was 51.7% bigger, at -31.85%. Month end -34.16% on 2026-01-30 |
| 40 | TORO Toro Corp. | -20.88% |
against the close of 2026-01-16
Session detail |
Buyback / Dividend |
Toro Corp. Announces Shareholder Election Results and Payment of Special Dividend
16:29 ET after hours |
Five sessions later the drop was 48.2% bigger, at -30.95%. Month end -31.14% on 2026-01-30 |
| 41 | CVCO Cavco Industries Inc. | -20.32% |
against the close of 2026-01-29
Session detail |
Earnings |
Cavco Industries Reports Fiscal 2026 Third Quarter Results
16:05 ET after hours |
37.2% of the drop was recovered five sessions later. Month end -20.32% on 2026-01-30 same session This month ended before the fifth session after the move. |
| 42 | AGYS Agilysys, Inc. | -19.98% |
against the close of 2026-01-26
Session detail |
Other Announcement |
Agilysys Announces 16th Consecutive Record Revenue Quarter: $80.4M in Fiscal 2026 Q3
16:05 ET after hours |
Five sessions later the drop was 30.8% bigger, at -26.14%. Month end -23.60% on 2026-01-30 This month ended before the fifth session after the move. |
| 43 | IESC IES Holdings, Inc. | -19.87% |
against the close of 2026-01-29
Session detail |
Earnings |
IES Holdings Reports Fiscal 2026 First Quarter Results
07:45 ET premarket |
80.1% of the drop was recovered five sessions later. Month end -19.87% on 2026-01-30 same session This month ended before the fifth session after the move. |
| 44 | GNLX Genelux Corporation More than one ranked move this month 2+ ranked moves | -19.76% |
against the close of 2026-01-07
Session detail |
Offering / Dilution |
Genelux Corporation Announces Proposed Public Offering of Common Stock
16:01 ET after hours |
Five sessions later the drop was 23.9% bigger, at -24.48%. Month end -21.53% on 2026-01-30 |
| 45 | NUVB Nuvation Bio Inc. | -19.65% |
against the close of 2026-01-09
Session detail |
Contract / Partnership |
Nuvation Bio and Eisai Enter into Exclusive Licensing Agreement for Taletrectinib in Europe and Additional Countries Outside U.S., China and Japan
07:30 ET premarket |
Five sessions later the drop was 28.5% bigger, at -25.25%. Month end -34.83% on 2026-01-30 |
| 46 | UNH UNITEDHEALTH GROUP INCORPORATED (Delaware) | -19.61% |
against the close of 2026-01-26
Session detail |
Guidance Change |
UnitedHealth Group Reports 2025 Results and Issues 2026 Outlook
05:55 ET premarket |
2.2% of the drop was recovered five sessions later. Month end -18.40% on 2026-01-30 This month ended before the fifth session after the move. |
| 47 | LXRX Lexicon Pharmaceuticals, Inc. | -19.44% |
against the close of 2026-01-29
Session detail |
Offering / Dilution |
Lexicon Announces Proposed Public Offering of Common Stock
16:31 ET after hours |
25.0% of the drop was recovered five sessions later. Month end -19.44% on 2026-01-30 same session This month ended before the fifth session after the move. |
| 48 | ASTI Ascent Solar Technologies, Inc. Also on the opposite board this month on both boards | -19.06% |
against the close of 2026-01-23
Session detail |
Offering / Dilution |
Ascent Solar Technologies Announces up to $25 Million Private Placement Priced At-The-Market Under Nasdaq Rules
08:00 ET premarket |
20.5% of the drop was recovered five sessions later. Month end -31.83% on 2026-01-30 This month ended before the fifth session after the move. |
| 49 | CLNN Clene Inc. | -19.00% |
against the close of 2026-01-09
Session detail |
Clinical Trial Results |
Clene Announces Additional CNM-Au8 Biomarker Data Supporting Potential NDA Filing for Upcoming In-Person FDA Meeting
08:30 ET premarket |
Five sessions later the drop was 37.1% bigger, at -26.04%. Month end -36.04% on 2026-01-30 |
| 50 | SIDU Sidus Space, Inc. | -18.56% |
against the close of 2026-01-23
Session detail |
Other Announcement |
Sidus Space and Maris‑Tech Achieve Integration Milestone for LizzieSat‑4 Mission
08:30 ET premarket |
Five sessions later the drop was 116.3% bigger, at -40.14%. Month end -35.03% on 2026-01-30 This month ended before the fifth session after the move. |
| 51 | NAVI Navient Corporation | -18.52% |
against the close of 2026-01-27
Session detail |
Earnings |
Navient posts fourth quarter 2025 financial results
06:45 ET premarket |
10.7% of the drop was recovered five sessions later. Month end -18.52% on 2026-01-30 This month ended before the fifth session after the move. |
| 52 | SUPX SuperX AI Technology Limited | -17.98% |
against the close of 2026-01-29
Session detail |
Other Announcement |
SuperX Commences Production at First Global Supply Center
06:00 ET premarket |
Five sessions later the drop was 41.2% bigger, at -25.38%. Month end -17.98% on 2026-01-30 same session This month ended before the fifth session after the move. |
| 53 | RGNX REGENXBIO Inc. | -17.90% |
against the close of 2026-01-27
Session detail |
FDA & Regulatory |
REGENXBIO Announces Regulatory Update on Ultra Rare MPS Programs
07:30 ET premarket |
Five sessions later the drop was 10.8% bigger, at -19.84%. Month end -16.78% on 2026-01-30 This month ended before the fifth session after the move. |
| 54 | DGNX Diginex Limited | -17.81% |
against the close of 2026-01-27
Session detail |
Leadership Change catalyst from a later release the same session |
Diginex Brings Carbon and Decarbonization Expertise Into the CEO Role
09:45 ET intraday |
Five sessions later the drop was 57.7% bigger, at -28.08%. Month end -24.66% on 2026-01-30 This month ended before the fifth session after the move. |
| 55 | ANF Abercrombie & Fitch Co. | -17.69% |
against the close of 2026-01-09
Session detail |
Guidance Change |
Abercrombie & Fitch Co. Provides Fourth Quarter and Fiscal Year Outlook Update
08:00 ET premarket |
Five sessions later the drop was 9.4% bigger, at -19.36%. Month end -21.81% on 2026-01-30 |
| 56 | WRLD World Acceptance Corp | -17.58% |
against the close of 2026-01-26
Session detail |
Earnings |
World Acceptance Corporation Reports Fiscal 2026 Third Quarter Results
07:30 ET premarket |
13.8% of the drop was recovered five sessions later. Month end -14.96% on 2026-01-30 This month ended before the fifth session after the move. |
| 57 | OESX Orion Energy Systems, Inc. | -17.43% |
against the close of 2026-01-29
Session detail |
Offering / Dilution |
Orion Announces Proposed Public Offering of Common Stock
16:43 ET after hours |
Five sessions later the drop was 36.3% bigger, at -23.75%. Month end -17.43% on 2026-01-30 same session This month ended before the fifth session after the move. |
| 58 | ALT Altimmune, Inc. | -17.15% |
against the close of 2026-01-27
Session detail |
Offering / Dilution |
Altimmune Announces Pricing of $75 Million Registered Direct Offering of Common Stock
21:25 ET after hours |
0.9% of the drop was recovered five sessions later. Month end -9.39% on 2026-01-30 This month ended before the fifth session after the move. |
| 59 | AUTL Autolus Therapeutics plc | -17.13% |
against the close of 2026-01-09
Session detail |
Other Announcement |
Autolus Therapeutics Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Net Product Revenue, Pipeline Advancements and Outlook for 2026
07:00 ET premarket |
Five sessions later the drop was 25.8% bigger, at -21.55%. Month end -24.31% on 2026-01-30 |
| 60 | POET POET Technologies Inc. | -17.08% |
against the close of 2026-01-21
Session detail |
Offering / Dilution |
POET Technologies Announces Pricing of US$150 Million Registered Direct Offering of Common Shares
08:19 ET premarket |
Five sessions later the drop was 69.3% bigger, at -28.91%. Month end -30.70% on 2026-01-30 |
| 61 | ARBE Arbe Robotics Ltd. | -17.06% |
against the close of 2026-01-23
Session detail |
Offering / Dilution |
Arbe Robotics Ltd. Announces $16 million Underwritten Registered Direct Offering
08:00 ET premarket |
Five sessions later the drop was 65.5% bigger, at -28.24%. Month end -27.65% on 2026-01-30 This month ended before the fifth session after the move. |
| 62 | TCOM Trip.com Group Limited American | -17.05% |
against the close of 2026-01-13
Session detail |
Other Announcement |
Announcement from Trip.com Group
04:42 ET premarket |
Five sessions later the drop was 5.2% bigger, at -17.94%. Month end -18.91% on 2026-01-30 |
| 63 | INTC Intel Corp | -17.03% |
against the close of 2026-01-22
Session detail |
Earnings |
Intel Reports Fourth-Quarter and Full-Year 2025 Financial Results
16:01 ET after hours |
15.1% of the drop was recovered five sessions later. Month end -14.45% on 2026-01-30 |
| 64 | CMCL Caledonia Mining Corporation Plc | -16.91% |
against the close of 2026-01-14
Session detail |
Offering / Dilution |
Caledonia Announces Proposed $100 Million Offering of Convertible Senior Notes Due 2033
16:05 ET after hours |
81.5% of the drop was recovered five sessions later. Month end -15.33% on 2026-01-30 |
| 65 | WLTH Wealthfront Corporation | -16.84% |
against the close of 2026-01-12
Session detail |
Earnings |
Wealthfront Reports Fiscal Third Quarter 2026 Results with Record Total Revenue of $93.2 Million and Net Income of $30.9 Million
16:05 ET after hours |
Five sessions later the drop was 73.1% bigger, at -29.15%. Month end -31.06% on 2026-01-30 |
| 66 | JOBY Joby Aviation, Inc. | -16.68% |
against the close of 2026-01-28
Session detail |
Offering / Dilution |
Joby Aviation Announces Proposed Offerings of Common Stock and Convertible Senior Notes
16:42 ET after hours |
Five sessions later the drop was 75.3% bigger, at -29.24%. Month end -20.94% on 2026-01-30 This month ended before the fifth session after the move. |
| 67 | CNDT Conduent Incorporated | -16.58% |
against the close of 2026-01-16
Session detail |
Leadership Change |
Conduent Appoints Harsha V. Agadi as Chief Executive Officer
16:30 ET after hours |
Five sessions later the drop was 22.4% bigger, at -20.30%. Month end -31.19% on 2026-01-30 |
| 68 | TVGN Tevogen Inc. | -16.45% |
against the close of 2026-01-09
Session detail |
Other Announcement |
Tevogen Demonstrates Platform Scalability and Multi-Indication T Cell Pipeline Expansion in 2025
09:00 ET premarket |
Five sessions later the drop was 10.6% bigger, at -18.20%. Month end -21.93% on 2026-01-30 |
| 69 | DVLT Datavault AI Inc. Also on the opposite board this month on both boards | -16.12% |
against the close of 2026-01-06
Session detail |
Contract / Partnership |
Datavault AI Announces Experiential Marketing Collaboration with New York’s Fifth Avenue Luxury Retailer Riflessi to Enable Sponsored Immersive 3D Digital Twins of Inventory with ADIO(R) and DVHOLO(TM)
07:00 ET premarket |
Five sessions later the drop was 196.8% bigger, at -47.84%. Month end -51.24% on 2026-01-30 |
| 70 | LC LendingClub Corporation | -15.99% |
against the close of 2026-01-28
Session detail |
Earnings |
LendingClub Reports Fourth Quarter and Full Year 2025 Results
16:05 ET after hours |
Five sessions later the drop was 24.0% bigger, at -19.83%. Month end -13.59% on 2026-01-30 This month ended before the fifth session after the move. |
| 71 | TBBK The Bancorp Inc. | -15.72% |
against the close of 2026-01-29
Session detail |
Buyback / Dividend |
The Bancorp Reports 4Q 2025 EPS of $1.28, ROA of 2.53% and ROE of 30.4% Driven by NIM of 4.30%, Continued Fintech Fee Growth, and $150 Million in Share Repurchases in the Quarter
16:25 ET after hours |
23.2% of the drop was recovered five sessions later. Month end -15.72% on 2026-01-30 same session This month ended before the fifth session after the move. |
| 72 | ATOM Atomera Incorporated | -15.41% |
against the close of 2026-01-27
Session detail |
Other Announcement |
Atomera’s GaN-on-Silicon Concept Advances to Proposal Phase in Funding Program
17:05 ET after hours |
Five sessions later the drop was 60.7% bigger, at -24.77%. Month end -11.48% on 2026-01-30 This month ended before the fifth session after the move. |
| 73 | KLAC KLA Corporation | -15.24% |
against the close of 2026-01-29
Session detail |
Earnings |
KLA Corporation Reports Fiscal 2026 Second Quarter Results
16:05 ET after hours |
5.8% of the drop was recovered five sessions later. Month end -15.24% on 2026-01-30 same session This month ended before the fifth session after the move. |
| 74 | SAP SAP SE | -15.20% |
against the close of 2026-01-28
Session detail |
Other Announcement |
SAP Quarterly Statement Q4 2025
00:00 ET premarket |
Five sessions later the drop was 7.8% bigger, at -16.39%. Month end -14.85% on 2026-01-30 This month ended before the fifth session after the move. |
| 75 | CATX Perspective Therapeutics, Inc. | -15.14% |
against the close of 2026-01-09
Session detail |
Other Announcement |
Perspective Therapeutics Provides Business Updates and Strategic Priorities Ahead of Presentation at 44th Annual J.P. Morgan Healthcare Conference
07:00 ET premarket |
4.6% of the drop was recovered five sessions later. Month end +33.45% on 2026-01-30 |
| 76 | APLS Apellis Pharmaceuticals, Inc. | -15.02% |
against the close of 2026-01-09
Session detail |
Other Announcement |
Apellis Highlights Commercial Execution and Strategic Priorities at the 44th Annual J.P. Morgan Healthcare Conference
07:00 ET premarket |
Five sessions later the drop was 66.6% bigger, at -25.02%. Month end -17.29% on 2026-01-30 |
| 77 | NRIM Northrim BanCorp Inc | -14.95% |
against the close of 2026-01-22
Session detail |
Other Announcement |
Northrim BanCorp Earns $12.4 Million, or $0.55 Per Diluted Share, in Fourth Quarter 2025, and $64.6 Million, or $2.87 Per Diluted Share, for the Year Ended December 31, 2025
09:00 ET premarket |
Five sessions later the drop was 38.1% bigger, at -20.65%. Month end -20.65% on 2026-01-30 |
| 78 | UAVS Also on the opposite board this month on both boards | -14.89% |
against the close of 2026-01-06
Session detail |
Other Announcement |
EagleNXT Delivers Mission-Critical Support to eBee VISION Drone Operations in the UAE
08:30 ET premarket |
It recovered the whole drop and closed 19.86% above the pre-news price. Month end -25.53% on 2026-01-30 |
| 79 | SSRM SSR Mining Inc. | -14.88% |
against the close of 2026-01-29
Session detail |
Earnings |
SSR Mining Announces Results of the Hod Maden Technical Report Summary With $1.66B NPV5% and 39% IRR
18:00 ET after hours |
33.3% of the drop was recovered five sessions later. Month end -14.88% on 2026-01-30 same session This month ended before the fifth session after the move. |
| 80 | VZLA Vizsla Silver Corp. | -14.87% |
against the close of 2026-01-28
Session detail |
Other Announcement |
VIZSLA SILVER PROVIDES AN UPDATE ON MEDIA-REPORTED SECURITY INCIDENT AT THE PANUCO PROJECT
18:08 ET after hours |
Five sessions later the drop was 151.9% bigger, at -37.46%. Month end -25.95% on 2026-01-30 This month ended before the fifth session after the move. |
| 81 | DCX Digital Currency X Technology Inc. More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards | -14.73% |
against the close of 2026-01-16
Session detail |
Other Announcement |
Digital Currency X Technology Inc. Announces 12 for 1 Share Consolidation
06:30 ET premarket |
Five sessions later the drop was 157.5% bigger, at -37.93%. Month end -33.47% on 2026-01-30 |
| 82 | TVTX Travere Therapeutics, Inc. | -14.63% |
against the close of 2026-01-12
Session detail |
Guidance Change |
Travere Therapeutics Provides Corporate Update and 2026 Outlook
17:00 ET after hours |
Five sessions later the drop was 17.3% bigger, at -17.16%. Month end -8.83% on 2026-01-30 |
| 83 | RGP Resources Connection | -14.61% |
against the close of 2026-01-07
Session detail |
Earnings |
Resources Connection Reports Financial Results for Second Quarter Fiscal 2026
16:05 ET after hours |
20.8% of the drop was recovered five sessions later. Month end -14.04% on 2026-01-30 |
| 84 | UAMY | -14.54% |
against the close of 2026-01-28
Session detail |
Other Announcement |
Inaccurate and Misleading Reuters Article
10:00 ET intraday |
Five sessions later the drop was 58.1% bigger, at -22.99%. Month end -24.43% on 2026-01-30 This month ended before the fifth session after the move. |
| 85 | GANX Gain Therapeutics, Inc. | -14.14% |
against the close of 2026-01-05
Session detail |
Other Announcement |
Gain Therapeutics Highlights Biomarker Evidence Supporting Disease-Modifying Potential of GT-02287
07:00 ET premarket |
Five sessions later the drop was 76.2% bigger, at -24.92%. Month end -39.39% on 2026-01-30 |
| 86 | CGAU Centerra Gold Inc. | -14.14% |
against the close of 2026-01-29
Session detail |
Other Announcement |
Centerra Gold Reports Explosion at Langeloth; No Fatalities or Significant Environmental Releases
07:45 ET premarket |
20.7% of the drop was recovered five sessions later. Month end -14.14% on 2026-01-30 same session This month ended before the fifth session after the move. |
| 87 | VNDA Vanda Pharmaceuticals Inc. | -14.05% |
against the close of 2026-01-07
Session detail |
Clinical Trial Results |
Vanda Pharmaceuticals Announces Receipt of FDA Decision Letter on HETLIOZ® Supplemental New Drug Application for Jet Lag Disorder
07:00 ET premarket |
9.2% of the drop was recovered five sessions later. Month end -11.71% on 2026-01-30 |
| 88 | LVS Las Vegas Sands Corp. | -13.96% |
against the close of 2026-01-28
Session detail |
Earnings |
Las Vegas Sands Reports Fourth Quarter 2025 Results
16:05 ET after hours |
49.5% of the drop was recovered five sessions later. Month end -13.92% on 2026-01-30 This month ended before the fifth session after the move. |
| 89 | EUDA EUDA Health Holdings Limited | -13.93% |
against the close of 2026-01-12
Session detail |
Contract / Partnership |
EUDA Enters into Convertible Loan Agreement with Shenzhen Inno, Further Expanding Stem Cell Therapy Platform
07:49 ET premarket |
Five sessions later the drop was 135.4% bigger, at -32.79%. Month end -48.77% on 2026-01-30 |
| 90 | APOG Apogee Enterprises Inc | -13.89% |
against the close of 2026-01-06
Session detail |
Earnings |
Apogee Enterprises Reports Fiscal 2026 Third Quarter Results
06:32 ET premarket |
66.2% of the drop was recovered five sessions later. Month end -0.43% on 2026-01-30 |
| 91 | OCGN Ocugen, Inc. | -13.83% |
against the close of 2026-01-14
Session detail |
Clinical Trial Results |
Ocugen Announces Positive Preliminary Phase 2 Data from OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
08:15 ET premarket |
15.4% of the drop was recovered five sessions later. Month end -22.87% on 2026-01-30 |
| 92 | UAN CVR Partners, LP | -13.82% |
against the close of 2026-01-23
Session detail |
Other Announcement |
CVR Energy Reports Preliminary Estimated Fourth Quarter and Full-Year 2025 Results
07:22 ET premarket |
Five sessions later the drop was 1.2% bigger, at -13.98%. Month end -12.50% on 2026-01-30 This month ended before the fifth session after the move. |
| 93 | PENG Penguin Solutions, Inc. | -13.78% |
against the close of 2026-01-06
Session detail |
Earnings |
Penguin Solutions Reports Q1 Fiscal 2026 Financial Results
16:05 ET after hours |
57.3% of the drop was recovered five sessions later. Month end -10.86% on 2026-01-30 |
| 94 | PHAT Phathom Pharmaceuticals, Inc. | -13.72% |
against the close of 2026-01-07
Session detail |
Offering / Dilution |
Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
16:05 ET after hours |
Five sessions later the drop was 25.0% bigger, at -17.15%. Month end -24.39% on 2026-01-30 |
| 95 | OR OR Royalties Inc. | -13.72% |
against the close of 2026-01-29
Session detail |
M&A / Acquisition |
OR Royalties Acquires Additional 1.0% NSR Royalty on the Namdini Gold Mine in Ghana
16:30 ET after hours |
9.4% of the drop was recovered five sessions later. Month end -13.72% on 2026-01-30 same session This month ended before the fifth session after the move. |
| 96 | AIRJ AirJoule Technologies Corporation | -13.60% |
against the close of 2026-01-13
Session detail |
Offering / Dilution |
AirJoule Technologies Announces Pricing of $20 Million Public Offering of Class A Common Stock
07:30 ET premarket |
44.4% of the drop was recovered five sessions later. Month end -18.89% on 2026-01-30 |
| 97 | EVTV Azio AI Holdings, Inc. Also on the opposite board this month on both boards | -13.59% |
against the close of 2026-01-20
Session detail |
Other Announcement |
Envirotech Vehicles Reaffirms Momentum With AZIO AI and Provides Update on Nasdaq Compliance Process
13:56 ET intraday |
Five sessions later the drop was 169.9% bigger, at -36.68%. Month end -48.10% on 2026-01-30 |
| 98 | ANGO AngioDynamics, Inc. | -13.53% |
against the close of 2026-01-05
Session detail |
Earnings |
AngioDynamics Reports Fiscal Year 2026 Second Quarter Financial Results; Continued Double Digit Med Tech Growth Drives Increased Profitability
06:00 ET premarket |
Five sessions later the drop was 76.6% bigger, at -23.89%. Month end -21.69% on 2026-01-30 |
NYSE and Nasdaq companies with a market capitalization of $25M or more, measured today. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. 585 smaller events this month are held out of this month's eligible pool; switch to include them. 361 events never entered this month's eligible pool, because the ticker is a warrant, a unit, a right or a preferred rather than common stock, is classed today as a fund, a trust or an index product, or carries a stored capitalization above $10 trillion, which is larger than any company has reached. Include the $5M to $25M band
2 events were left out of this board because the ticker had not traded for more than 10 days before the measured session, so no comparable prior close exists.
2 rows withhold a market cap because the vendor's stored figure disagrees with the share count and price it is derived from by more than a factor of three, counting the filed all-class share count where one exists.
Whole board, unfiltered
In January 2026, the median decliner was 13.7% deeper below its pre-news close five sessions later; the largest catalyst group was Other Announcement, 26 of the 98 events, at a median of -15.9%.
Close-to-close change on the measured trading session, against the previous close.
NYSE and Nasdaq companies with a market capitalization of $25M or more, measured today. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them.
Which catalysts drove the board
Swipe the table sideways for the day +5 columns.
| Catalyst | Events | Share of board | Median move close to close | Median at day +5 | Still below the pre-news close at day +5 |
|---|---|---|---|---|---|
| Other Announcement | 26 | 26.5% | -15.9% | -25.2% | 96.2% of 26 |
| Earnings | 21 | 21.4% | -17.6% | -15.2% | 95.2% of 21 |
| Offering / Dilution | 19 | 19.4% | -19.4% | -28.2% | 100.0% of 19 |
| Clinical Trial Results | 12 | 12.2% | -33.3% | -41.6% | 100.0% of 12 |
| Contract / Partnership | 6 | 6.1% | Fewer than 10 events in this group, so no figures are shown. | ||
7 other catalyst types, 14 events: Guidance Change, M&A / Acquisition, FDA & Regulatory, Uplisting / Compliance, Buyback / Dividend, Leadership Change, Crypto & Treasury.
How much of the drop held
| Horizon | Still below the pre-news close close to close | Median change since the measured close as a share of the drop |
|---|---|---|
| Day +1 | 99.0% of 98 | 4.3% deeper below baseline, of 98 |
| Day +5 | 98.0% of 98 | 13.7% deeper below baseline, of 98 |
| Month end | 98.8% of 86 | 24.7% deeper below baseline, of 86 |
| Month end falls before day +5 for 30 of these 86 events, so this row is not a later horizon than the one above it. 86 of the 98 events have a month-end close later than the measured session; 12 have it on the measured session itself. | ||
Both figures in a row are measured over the events that have a close at that horizon, the count printed beside each of them, not over all 98 events on this board, which is why the denominators differ between rows.
Repeat runners
Some companies move on news more than once. The left list holds the ones that moved twice or more this month; the right list holds the ones that also moved in the months before it. The ranking above shows one row per move, so a name that keeps coming back is only visible here.
Moved twice or more inside January 2026
Two or more ranked moves this month, each on a different trading day.
| Symbol | Measured sessions | Largest drop |
|---|---|---|
| ROLRHigh Roller Technologies, Inc. | 2Contract / Partnership, Offering / Dilution | -28.93% |
| DCXDigital Currency X Technology Inc. | 2Uplisting / Compliance, Other Announcement | -25.68% |
| GNLXGenelux Corporation | 2Clinical Trial Results, Offering / Dilution | -23.52% |
Also fallen on news in earlier months
Ranked in at least two of the three months before this one. They are listed whether or not they rank this month, which is why the months are named.
| Symbol | Months | Largest drop |
|---|---|---|
| VBIXViewbix Inc. | 2025-12, 2025-11 | -42.32% |
| CLNNClene Inc.this month too | 2025-12, 2025-11 | -22.42% |
| DVLTDatavault AI Inc.this month too | 2025-12, 2025-10 | -19.96% |
| HITHealth In Tech, Inc. | 2025-12, 2025-11 | -26.37% |
| EVAXEvaxion A/S | 2025-12, 2025-10 | -29.27% |
| EDSAEdesa Biotech, Inc. | 2025-12, 2025-10 | -17.87% |
| SOCSable Offshore Corp. | 2025-11, 2025-10 | -30.50% |
| TGEThe Generation Essentials Group | 2025-11, 2025-10 | -53.71% |
| NTLAIntellia Therapeutics, Inc | 2025-11, 2025-10 | -42.23% |
What the board was made of
Price before the move
When the announcement landed
Volume against normal
1 event has too little trading history for a relative volume, and is not in the tiers above.
Industry
30 other industries, 35 events
Industry not known: 16.3%
3 events on this board carry the flag for a move that ran against its own release, too few to say whether the flag predicts anything.
Against December 2025
99 events in the comparable window.
December 2025 median -21.6%, selected from the 6,204 events in that month's eligible pool
January 2026 median -18.8%, 2.8 points shallower than December 2025. January 2026's median is taken over the 98 ranked rows, selected from the 7,945 events in that month's eligible pool.
The two windows drew on pools of very different size, so part of the gap between the medians is how deep into each pool the top hundred reaches rather than how severe the moves were.
How this ranking is measured
Close-to-close change on the measured trading session, against the previous close.
- An announcement before 16:00 ET is measured on that trading day; one at or after 16:00 ET, or on a weekend, is measured on the next trading day.
- One row per company and measured session. Other announcements the company made in the same session are listed inside the row.
- A ranking is a coincidence of news and price on the same session, not proof that the news caused the move. Part of an intraday move can precede the announcement.
- No Stated Cause marks a release in which the company itself says it knows of no reason for the move, while Other Announcement marks a release these rules could not classify.
Eligibility uses each company's capitalization today, not its capitalization at the time. Archive boards can therefore change as companies grow or shrink.
Prices are adjusted for stock splits the company has done since, so an older row's dollar figures are stated on today's share count and are not the prices that traded that day. The percentage move, the dollar volume and the relative volume are unaffected, because both prices carry the same adjustment.
Market cap is not shown on months older than a year, because only today's figure exists. Market cap is not shown because the stored figure disagrees with the share count and price it is derived from.
NYSE and Nasdaq companies with a market capitalization of $25M or more, measured today. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them.
This archive starts at 2020-04, the first month with ranked moves.